/Companies

Stream Biomedical

Houston, US · Delaware corporation · 2 known investors

Find your way into Stream Biomedical

Sign up to find every way you can get introduced to Stream Biomedical

  • Your email: who you already know at Stream Biomedical, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Stream Biomedical team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Stream Biomedical is a clinical-stage biotechnology company developing LG3, a biologic derived from a natural repair protein intended to protect and restore the brain by activating its repair systems. Its lead program targets Alzheimer's disease and related dementias, with potential use in stroke, traumatic brain injury, and other neurological conditions.

Founders & leadership

HD
H. Davis AdkissonChief Scientific Officer
CG
Chris GarabedianNamed on SEC filing
WS
William SchwietermanBoard of Directors
FC
Fred CalloriNamed on SEC filing
BC
Bryan ClossenDirector of Translational Programs
SF
Seth Fisher

Board

ADAmanda De La Garza
Amanda De La GarzaBoard directorPartner at Bios Partners

Investors · 2

Reported raises · per SEC filings

Form D private placements

$21.5M disclosed across 1 round · 2021

▶$21.5MraisedJan 2022 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris GarabedianDirector
  • Amanda De La GarzaDirector
  • William SchwietermanExecutive Officer, Director
  • Fred CalloriDirector
Offering amount
$21.5M
Amount sold
$21.5M
Minimum investment
$50K
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Stream Biomedical.

Frequently asked questions

What does Stream Biomedical do?
Stream Biomedical is a clinical-stage biotechnology company developing LG3, a biologic derived from a natural repair protein intended to protect and restore the brain by activating its repair systems. Its lead program targets Alzheimer's disease and related dementias, with potential use in stroke, traumatic brain injury, and other neurological conditions.
Who are Stream Biomedical's investors?
Stream Biomedical's investors include Bios Partners, Cowtown Angels.
How much funding has Stream Biomedical raised?
Stream Biomedical has disclosed $21.5M raised across 1 round.
Where is Stream Biomedical headquartered?
Stream Biomedical is headquartered in Houston, US.